Download video

KRAS G12C Inhibitors Versus Chemotherapy in Second Line - Targeted Therapies in Lung Cancer 2023

242 views

Global Resource for Advancing Cancer Education

2 years ago

KRAS G12C Inhibitors Versus Chemotherapy in Second Line - Targeted Therapies in Lung Cancer 2023

KRAS G12C Inhibitors Versus Chemotherapy in Second Line - Targeted Therapies in Lung Cancer 2023

KRAS G12C Inhibitors Versus Chemotherapy in Second Line - Targeted Therapies in Lung Cancer 2023
3:56
KRAS G12C Inhibitors Versus Chemotherapy in Second Line - Targeted Therapies in Lung Cancer 2023
by Global Resource for Advancing Cancer Education
KRAS G12C Emerges as New Potential Target in Non-Small Cell Lung Cancer
0:50
KRAS G12C Emerges as New Potential Target in Non-Small Cell Lung Cancer
by Targeted Oncology
Targeted Therapy for KRAS p.G12C NSCLC
2:49
Targeted Therapy for KRAS p.G12C NSCLC
by OncLive
Evaluating first-line olomorasib and chemo-IO in KRAS G12C NSCLC
1:41
Evaluating first-line olomorasib and chemo-IO in KRAS G12C NSCLC
by VJOncology
Learning More about KRAS Lung Cancer
2:17
Learning More about KRAS Lung Cancer
by American Lung Association
KRAS G12C Inhibition in Advanced NSCLC: MRTX849
2:53
KRAS G12C Inhibition in Advanced NSCLC: MRTX849
by Targeted Oncology
Highlights from WCLC 2022: KRAS-mutant lung cancer
0:30
Highlights from WCLC 2022: KRAS-mutant lung cancer
by VJOncology
It's KRAS Biomarker Lung Cancer. What Do I Do Now?
2:35
It's KRAS Biomarker Lung Cancer. What Do I Do Now?
by Lung Cancer Foundation of America
Sotorasib shows as a tolerable treatment option for patients with KRASG12C-mutated advanced NSCLC
4:19
Sotorasib shows as a tolerable treatment option for patients with KRASG12C-mutated advanced NSCLC
by ecancer
The potential of KRAS inhibitors for non-small-cell lung cancer
10:34
The potential of KRAS inhibitors for non-small-cell lung cancer
by ecancer
Case 2: Frontline Treatment Data in Stage IV NSCLC
4:15
Case 2: Frontline Treatment Data in Stage IV NSCLC
by Targeted Oncology
What are the latest developments in KRAS-mutant NSCLC?
4:01
What are the latest developments in KRAS-mutant NSCLC?
by VJOncology
Unmet needs in KRAS-driven non-small cell lung cancer
0:41
Unmet needs in KRAS-driven non-small cell lung cancer
by VJOncology